Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Turgay Ulaş"'
Autor:
İstemi Serin, Mehmet Hilmi Doğu, Ömer Ekinci, Gülsüm Akgün Çağlıyan, Abdulkadir Baştürk, Merih Reis Aras, Sinan Demircioğlu, Burhan Turgut, Mustafa Merter, Sibel Kabukçu Hacıoğlu, Metin Bağcı, Murat Albayrak, Serdal Korkmaz, Mehmet Ali Erkurt, Mehmet Sinan Dal, Fadime Ersoy Dursun, Anıl Tombak, İsmet Aydoğdu, Turgay Ulaş, Fevzi Altuntaş
Publikováno v:
İstanbul Medical Journal, Vol 24, Iss 2, Pp 120-125 (2023)
Introduction:Ruxolitinib is a small -molecule inhibitor of the JAK1/2 pathway. This study aimed to reveal the results and side-effect profile of the use of ruxolitinib as a treatment option in polycythemia vera (PV).Methods:A total of 34 patients wit
Externí odkaz:
https://doaj.org/article/2f9813f1062246cfa7c5bb2a592ed5f8
Prognostic Significance of Flow Cytometric Immunophenotyping in Patients with Acute Myeloid Leukemia
Publikováno v:
Bezmiâlem Science, Vol 10, Iss 4, Pp 402-408 (2022)
Objective:Chromosomal abnormalities are one of the most important prognostic factors in acute myeloid leukemia (AML). However, not all patients may have such informative chromosomal abnormalities. Although there are many studies on the prognostic val
Externí odkaz:
https://doaj.org/article/6216e4967c524ad7bc6db8917f8320da
Autor:
Deniz GRANİT SEMAVİ, Turgay ULAŞ
Publikováno v:
Cukurova Medical Journal. 47:1753-1755
Kikuchi Fujimoto disease (KFD) is a rare, generally benign and self limited condition with an unknown etiology. There isn’t a guideline for treatment of KFD, recommendations for treatment are based on clinical experience and management is typically
Autor:
Ozgur Sirkeci, Emel Erkus Sirkeci, Neslihan Ergün Süzer, Ali Cankut Tatlıparmak, Yasemin Küçükçiloğlu, Turgay Ulaş
Publikováno v:
Wiener klinische Wochenschrift.
Publikováno v:
Acta Oncologica Turcica. 55:103-108
Autor:
Mehmet Sinan Dal, Bahar Uncu Ulu, Ant Uzay, Olga Meltem Akay, Sevgi Beşışık, Mustafa Nuri Yenerel, Serhat Çelik, Leylagül Kaynar, Orhan Kemal Yücel, Burak Deveci, Mehmet Sönmez, Özgür Mehtap, Hüseyin Saffet Beköz, Cenk Sunu, Ozan Salim, Turgay Ulaş, Sami Kartı, Fevzi Altuntaş, Burhan Ferhanoğlu, Tülin Fırat Tuğlular
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.Polatuzumab vedotin (Pola) with bendamustine and rituximab (BR) is a promising option for patients with relapsed/refractory (R/R) diffuse large B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7c00cd4c281e383f205b4688df81ba
https://avesis.kayseri.edu.tr/publication/details/b6234c55-fa08-48f6-98b5-80650f4ac594/oai
https://avesis.kayseri.edu.tr/publication/details/b6234c55-fa08-48f6-98b5-80650f4ac594/oai
Publikováno v:
Cyprus Journal of Medical Sciences. 7:346-348
Autor:
Uğurcan BALYEMEZ, Turgay ULAŞ
Publikováno v:
Turkiye Klinikleri Journal of Case Reports. 30:205-207
Publikováno v:
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences. 27
In this study, we aimed to evaluate whether waterpipe smoking can be associated with the transmission ofBetween March 2018 and April 2019, 445 patients aged over 18 years old who were admitted to outpatient clinics with dyspeptic complaints were recr
Publikováno v:
Tuberkuloz ve toraks. 64(3)